PIONEERS WIN!

Welcome to the Jennewein Competition:

Secure your chance to win one of three iPad Pros! All you need to do is correctly answer the question below about human milk oligosaccharides (HMOs).

Breastfeeding reduces the risk of infectious diseases in children by up to 50%. HMOs play a major role in this process. Jennewein Biotechnologie is the pioneer and inventor of a unique fermentation process for the production of HMOs identical to those present in human breast milk. Since 2005, our aim has been to develop new production processes for complex oligosaccharides. In 2015, we introduced our first food-grade HMO (2ʹ-fucosyllactose) on the market and received FDA/GRAS approval in the US and registered novel food status in Europe.
For more information about Jennewein and HMOs click here.
JOIN THE
JENNEWEIN
COMPETITION

Just choose the correct answer, fill out the form, click “Send” and you will be entered in our prize draw for one of three iPad Pros (12,9 inch/64GB/WiFi)!

Participation deadline: 29 November 2018

Bild lädt nicht

WHICH ARE THE THREE MOST IMPORTANT KEY BENEFITS OF HUMAN MILK OLIGOSACCHARIDES?

Prebiotic effect/ Reduced risk of developing non-communicable diseases/ Anti-adhesive effect

Low calories / Simple sugar molecules / Antibiotic effect

Adherence of pathogens to epithelial cells / Probiotic / Sweet taste

Which fair will you join?

Date Name of the Fair Location
11.-12.09.2018 Vitafoods Asia Singapore
03.-05.10.2018 HI Japan Tokyo
25.10.2018 SCIECON Munich
25.-28.10.2018 NASPGHAN Los Angeles, Hollywood
31.10.-02.11.2018 The World Microbiome Conference Milan
06.-10.11.2018 Supply Side West Las Vegas
13.-15.11.2018 Microbiome Human Nutrition Boston
14.-15.11.2018 4th Annual European Microbiome Congress London
27.-29.11.2018 HI Europe Frankfurt/Main

* Required fields